Eli Lilly to Invest $5 Billion in New Virginia Drug Manufacturing Plant
PositiveHealth

Eli Lilly has announced a $5 billion investment in a new drug manufacturing plant in Virginia. This initiative is part of the company's commitment to enhance domestic medicine production with four new sites.
Editor’s Note: This investment is significant as it reflects Eli Lilly's dedication to increasing local pharmaceutical production, which can lead to job creation and improved access to medications in the U.S.
— Curated by the World Pulse Now AI Editorial System